[Other] Addition of PI3K/AKT/mTOR inhibitors to fulvestrant for advanced HR+/HER2- breast cancer: a systematic review and meta-analysis

newmetasoon Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-31 14:11
Reward20points

need it urgently

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
huan2003 Post time 1 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    0


Return to the list